Long‐term prognosis in breast cancer is associated with residual disease after neoadjuvant systemic therapy but not with initial nodal status

BACKGROUND: This follow‐up analysis of a Swedish prospective multicentre trial had the primary aim to determine invasive disease‐free (IDFS), breast cancer‐specific (BCSS) and overall survival (OS) rates, and their association with axillary staging results before and after neoadjuvant systemic thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Zetterlund, L, Celebioglu, F, Hatschek, T, Frisell, J, de Boniface, J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364852/
https://www.ncbi.nlm.nih.gov/pubmed/34043772
http://dx.doi.org/10.1002/bjs.11963

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364852/
https://www.ncbi.nlm.nih.gov/pubmed/34043772
http://dx.doi.org/10.1002/bjs.11963

Ejemplares similares